I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Homicsko, K.
51
results:
english X
Search for persons
X
Format
Online (51)
Mediatypes
Articles (Online) (14)
OpenAccess-fulltext (37)
Sorted by: Relevance
Sorted by: Year
?
1
B-cell infiltration is associated with survival outcomes fo..:
Gavrielatou, N.
;
Fortis, E.
;
Spathis, A.
...
Annals of Oncology. 35 (2024) 4 - p. 340-350 , 2024
Link:
https://doi.org/10.1016/..
?
2
11P Association of VISTA-expressing CD66b-positive neutroph..:
Homicsko, K.
;
Zygoura, P.
;
Tissot, S.
...
Immuno-Oncology and Technology. 16 (2022) - p. 100116 , 2022
Link:
https://doi.org/10.1016/..
?
3
Turning tumors from cold to inflamed to improve immunothera..:
Gerard, C.L.
;
Delyon, J.
;
Wicky, A.
...
Cancer Treatment Reviews. 101 (2021) - p. 102227 , 2021
Link:
https://doi.org/10.1016/..
?
4
Late-onset and long-lasting immune-related adverse events f..:
Ghisoni, E.
;
Wicky, A.
;
Bouchaab, H.
...
European Journal of Cancer. 149 (2021) - p. 153-164 , 2021
Link:
https://doi.org/10.1016/..
?
5
A phase I/II study of chemo-immunotherapy with durvalumab (..:
O'Cearbhaill, R.E.
;
Homicsko, K.
;
Wolfer, A.
...
Gynecologic Oncology. 159 (2020) - p. 41 , 2020
Link:
https://doi.org/10.1016/..
?
6
Cancer Immunotherapy: A Simple Guide for Interventional Rad..:
Digklia, A.
;
Duran, R.
;
Homicsko, K.
...
CardioVascular and Interventional Radiology. 42 (2018) 9 - p. 1221-1229 , 2018
Link:
https://doi.org/10.1007/..
?
7
Phase I trial of the oral smoothened inhibitor sonidegib in..:
Stathis, A.
;
Hess, D.
;
von Moos, R.
...
Investigational New Drugs. 35 (2017) 6 - p. 766-772 , 2017
Link:
https://doi.org/10.1007/..
?
8
Compact solid-state CMOS single-photon detector array for i..:
Homulle, H. A. R.
;
Powolny, F.
;
Stegehuis, P. L.
...
Biomedical Optics Express. 7 (2016) 5 - p. 1797 , 2016
Link:
https://doi.org/10.1364/..
?
9
3356 Triple wild type melanoma profiling in the Caris Molec..:
Homicsko, K.
;
Kenneth, R.
;
Voss, A.
.
European Journal of Cancer. 51 (2015) - p. S687 , 2015
Link:
https://doi.org/10.1016/..
?
10
340 A phase I study of the smoothened (SMO) antagonist LDE2..:
Stathis, A.
;
Hess, D.
;
Xyrafas, A.
...
European Journal of Cancer. 51 (2015) - p. S67 , 2015
Link:
https://doi.org/10.1016/..
?
11
505 Clinical evidence of intra-tumoral immune activation an..:
Tabernero, J.
;
Homicsko, K.
;
Schellens, J.H.
...
European Journal of Cancer. 51 (2015) - p. S104-S105 , 2015
Link:
https://doi.org/10.1016/..
?
12
Salsolinol is a Putative Endogenous Neuro‐intermediate Lobe..:
Tóth, B. E.
;
Homicskó, K.
;
Radnai, B.
...
Journal of Neuroendocrinology. 13 (2001) 12 - p. 1042-1050 , 2001
Link:
https://doi.org/10.1046/..
?
13
Response and Resistance to Trametinib in MAP2K1-Mutant Trip..:
Krebs, F.S
;
Moura, B
;
Missiaglia, E
...
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms24054520. , 2023
Link:
https://serval.unil.ch/n..
?
14
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity res..:
Tichet, M
;
Wullschleger, S
;
Chryplewicz, A
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.immuni.2022.12.006. , 2023
Link:
https://serval.unil.ch/n..
?
15
Deep and lasting response and acquired resistance to BRAFV6..:
Anchisi, S
;
Wolfer, A
;
Bisig, B
...
info:eu-repo/semantics/altIdentifier/doi/10.1080/15384047.2023.2193116. , 2023
Link:
https://serval.unil.ch/n..
1-15